123 related articles for article (PubMed ID: 17561720)
1. [Prostate cancer diagnosed through the biopsy of the bone metastatic lesion; a case report].
Ueda Y; Higuchii Y; Hashimoto T; Mitsui Y; Maruyamai T; Kondou N; Nojima M; Yamamoto S; Shincho M; Hirota S; Shima H
Hinyokika Kiyo; 2007 May; 53(5):327-30. PubMed ID: 17561720
[TBL] [Abstract][Full Text] [Related]
2. [Recrudescence of prostate cancer with low serum level of PSA and high serum level of CEA and CA19-9: a case report].
Yokoyama S; Fukuhara S; Imazu T; Hara T; Yamaguchi S; Adachi S
Hinyokika Kiyo; 2007 Jul; 53(7):485-7. PubMed ID: 17702183
[TBL] [Abstract][Full Text] [Related]
3. [Prostate cancer with high serum level of CEA and CA19-9: a case report].
Momma T; Kimura S; Saito S; Onoda N
Hinyokika Kiyo; 1998 Mar; 44(3):187-91. PubMed ID: 9589883
[TBL] [Abstract][Full Text] [Related]
4. [A case of prostate cancer diagnosed pathologically by bone metastatic site biopsy].
Nakata S; Nakano K; Takahashi H; Shimizu K; Higashi H; Ohki K
Nihon Hinyokika Gakkai Zasshi; 2005 May; 96(4):507-10. PubMed ID: 15948412
[TBL] [Abstract][Full Text] [Related]
5. [Paget's disease mimicking metastatic prostate cancer on bone scan image : a case report].
Fukushi K; Koie T; Yamamoto H; Okamoto A; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
Hinyokika Kiyo; 2013 Apr; 59(4):247-50. PubMed ID: 23635462
[TBL] [Abstract][Full Text] [Related]
6. A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.
Iwamura H; Hatakeyama S; Tanaka Y; Tanaka T; Tokui N; Yamamoto H; Imai A; Yoneyama T; Hashimoto Y; Koie T; Yoshikawa K; Ohyama C
BMC Res Notes; 2014 Jan; 7():64. PubMed ID: 24476098
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between pretreatment serum levels of prostate specific antigen and bone metastasis in prostate cancer].
Kageyama Y; Kihara K; Kamata S; Nagahama K; Yonese J; Fukuda H; Tosaka A; Nagamatsu H; Ishizaka K; Tsujii T; Kitahara S; Morita T; Oshima H
Hinyokika Kiyo; 1996 Mar; 42(3):197-9. PubMed ID: 8619388
[TBL] [Abstract][Full Text] [Related]
8. The value of a baseline bone scan in patients with newly diagnosed prostate cancer.
Lin K; Szabo Z; Chin BB; Civelek AC
Clin Nucl Med; 1999 Aug; 24(8):579-82. PubMed ID: 10439178
[TBL] [Abstract][Full Text] [Related]
9. [Does PSA of less than 20 ng/ml exclude the diagnosis of metastatic prostate cancer?].
Amsellem D; Ogiez N; Salomon L; Chopin D; Abbou CC; Colombel M
Prog Urol; 1998 Dec; 8(6):1018-21. PubMed ID: 9894261
[TBL] [Abstract][Full Text] [Related]
10. When is a bone scan study appropriate in asymptomatic men diagnosed with prostate cancer?
Pal RP; Thiruudaian T; Khan MA
Asian J Androl; 2008 Nov; 10(6):890-5. PubMed ID: 18958353
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen and carbohydrate antigen 19-9-producing adenocarcinoma of the prostate: report of an autopsy case.
Kodama S; Itoh H; Ide H; Kataoka H; Takehara T; Nagano M; Hamasuna R; Koono M; Osada Y
Urol Int; 1999; 63(3):193-7. PubMed ID: 10738193
[TBL] [Abstract][Full Text] [Related]
12. [Recrudescent prostate cancer with a low serum PSA level and a high serum CEA level treated with docetaxel : a case report].
Fujita M; Goto T; Uchida K; Saiki S; Arima R
Hinyokika Kiyo; 2013 Mar; 59(3):183-8. PubMed ID: 23633635
[TBL] [Abstract][Full Text] [Related]
13. The clinical value of prostate-specific antigen and bone scintigraphy in the staging of patients with newly diagnosed, pathologically proven prostate cancer.
Rudoni M; Antonini G; Favro M; Baroli A; Brambilla M; Cardani G; Ciardi L; Sacchetti GM; Inglese E
Eur J Nucl Med; 1995 Mar; 22(3):207-11. PubMed ID: 7540551
[TBL] [Abstract][Full Text] [Related]
14. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan.
Kosuda S; Yoshimura I; Aizawa T; Koizumi K; Akakura K; Kuyama J; Ichihara K; Yonese J; Koizumi M; Nakashima J; Fujii H
Cancer; 2002 Feb; 94(4):964-72. PubMed ID: 11920464
[TBL] [Abstract][Full Text] [Related]
15. Early diagnosis of prostate cancer in the Western Cape.
Heyns CF; Naudé AM; Visser AJ; Marais DC; Stopforth HB; Nyarko JK; Stellmacher GA
S Afr Med J; 2001 Aug; 91(8):679-84. PubMed ID: 11584784
[TBL] [Abstract][Full Text] [Related]
16. Relapsed prostate cancer with neuroendocrine differentiation and high serum levels of carcinoembryonic antigen without elevation of prostrate-specific antigen: a case report.
Kinebuchi Y; Noguchi W; Irie K; Nakayama T; Kato H; Nishizawa O
Int J Urol; 2007 Feb; 14(2):147-9. PubMed ID: 17302572
[TBL] [Abstract][Full Text] [Related]
17. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of transrectal ultrasound guided biopsy in patients over 70 years old with a prostate specific Antigen (PSA) level ≤ 15 ng/ml and normal digital rectal examination: a 10-year prospective follow-up study of 427 consecutive patients.
Mohamed ZK; Dominguez-Escrig J; Vasdev N; Bharathan B; Greene D
Urol Oncol; 2013 Nov; 31(8):1489-96. PubMed ID: 22591749
[TBL] [Abstract][Full Text] [Related]
19. MRI of the skeleton in prostate cancer staging.
Rydh A; Lundblad M; Ahlström KR; Tavelin B; Stattin P
Scand J Urol Nephrol; 2003; 37(3):222-5. PubMed ID: 12775281
[TBL] [Abstract][Full Text] [Related]
20. [Systematic ultrasound guided transrectal core prostate biopsy based on serum level of prostate-specific antigen].
Yamaguchi S; Baba Y; Naito K
Hinyokika Kiyo; 1997 Sep; 43(9):641-5. PubMed ID: 9365843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]